RxDoctor Payments Data

Wanda Knudson

Physician Assistant · Bismarck, NDNPI 1760581714

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $840 and has fallen 95.3% since, to $39 in 2024.

$2,002in general payments, 2019–2025

Across 126 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$346
  • Johnson & Johnson$295
  • Boehringer Ingelheim$290
  • E.r. Squibb & Sons, L.L.C.$234
  • Novartis$195
  • Amgen$156
  • plus $486 from 13 others

What the payments were for

  • Food & beverage$2,002100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,002 in reported general payments places this provider in the 85th percentile of 355 physician assistant providers in North Dakota.

See all physician assistant providers in North Dakota

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban169$146,357
XareltoRivaroxaban45$46,244
Repatha SureclickEvolocumab25$13,857
Praluent PenAlirocumab23$13,514
Repatha SyringeEvolocumab18$11,929
EntrestoSacubitril/Valsartan14$11,034
Metoprolol Succinate397$8,884
Rosuvastatin Calcium383$6,315
Ezetimibe111$3,038
Atorvastatin Calcium216$3,016
Isosorbide Mononitrate ErIsosorbide Mononitrate86$2,371
Losartan Potassium187$2,188
Bumetanide24$1,732
Potassium Chloride56$1,651
Digoxin45$1,335

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$346$146,357169 claims
Johnson & JohnsonXarelto$295$46,24445 claims
NovartisEntresto$195$11,03414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 355 physician assistant providers in North Dakota.

Other physician assistant in Bismarck

See the full list for North Dakota

Where these figures come from

Is this you, or does something look wrong? →